Dendrimer-Based Drug Delivery Systems for Brain Targeting

Area of Science:

• Neuroscience
• Nanotechnology
• Pharmacology

Background:

• The blood-brain barrier (BBB) significantly restricts drug delivery to the central nervous system (CNS), leading to undertreatment of neurological diseases.
• Nanocarriers have been developed to overcome BBB limitations and facilitate brain drug delivery.

Purpose of the Study:

• To review research on dendrimer-based nanocarriers for effective and secure drug delivery across the BBB.
• To highlight the potential of dendrimers in enhancing therapeutic agent delivery for neurological disorders.

Main Methods:

• Review of extensive research on dendrimer applications in drug delivery.
• Analysis of dendrimer properties, including uniform size, multi-functionalization, and internal cavities.
• Evaluation of dendrimers for transporting small molecules, peptides, and genes.

Main Results:

• Dendrimers demonstrate potential for targeted drug delivery across the BBB.
• Their unique structure allows for versatile functionalization and payload incorporation.
• Dendrimers can reduce drug cytotoxicity and improve therapeutic efficacy in the CNS.

Conclusions:

• Dendrimer-based nanocarriers represent a secure and effective strategy for overcoming BBB challenges in treating neurological conditions.
• Further research into dendrimer applications holds significant promise for advancing CNS therapeutics.